Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.68
-0.19 (-1.93%)
Jul 15, 2026, 4:00 PM EDT - Market closed

Replimune Group Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
209.02111.1274.46146.59105.95
Short-Term Investments
59.87372.69346.21436.8289.71
Cash & Short-Term Investments
268.89483.8420.67583.39395.66
Cash Growth
-44.42%15.01%-27.89%47.45%-16.93%
Other Receivables
1.623.734.922.943.06
Total Trade Receivables
1.623.734.922.943.06
Other Current Assets
8.618.358.086.285.27
Total Current Assets
279.12495.88433.67592.6403.98
Net Property, Plant & Equipment
48.6252.5552.3652.3555.58
Other Long-Term Assets
4.652.91.71.641.64
Total Assets
332.39551.33487.72646.59461.19
Accounts Payable
6.6712.462.585.363.73
Accrued Expenses
47.5245.9233.9824.713.39
Current Portion of Leases
4.043.983.883.763.63
Total Current Liabilities
58.2362.3640.4433.8320.76
Long-Term Debt
83.3146.3844.8128.65-
Long-Term Leases
24.2425.8127.1828.3529.21
Other Long-Term Liabilities
0.460.940.790.47-
Total Long-Term Liabilities
10873.1272.7857.4729.21
Total Liabilities
166.23135.49113.2191.349.96
Common Stock
0.080.080.060.060.05
Additional Paid-in Capital
1,4231,3591,0711,035723.36
Accumulated Other Comprehensive Income
5.45.454.865.73-0.97
Retained Earnings
-1,263-948.58-701.28-485.49-311.2
Shareholders' Equity
166.16415.84374.51555.29411.23
Total Liabilities & Equity
332.39551.33487.72646.59461.19
Total Debt
111.5976.1775.8760.7632.84
Net Cash (Debt)
157.3407.64344.8522.63362.82
Net Cash Growth
-61.41%18.22%-34.03%44.05%-18.10%
Net Cash Per Share
1.705.065.188.986.95
Book Value
166.16415.84374.51555.29411.23
Book Value Per Share
1.795.165.639.547.88
Tangible Book Value
166.16415.84374.51555.29411.23
Tangible Book Value Per Share
1.795.165.639.547.88
SEC Filings: 10-K · 10-Q